发明名称 B-CELL AFFINITIVE LIGAND, B-CELL SEPARATION MATERIAL, AND B-CELL SEPARATION METHOD
摘要 PROBLEM TO BE SOLVED: To provide a B-cell affinitive ligand and a B-cell separation material that are less expensive and stable to sterilization, excellent in the property of selecting B cells and are suited to an extracorporeal circulation therapy. SOLUTION: The B-cell separation material has an aromatic fused ring as its skeleton and an organic low-molecular weight ligand having 2 or more and 10 or less non-dissociative hydrophilic substituents in a molecule on the surface of a water-insoluble carrier. And the B-cell affinitive organic low- molecular weight ligand has an aromatic fused ring as its skeleton and owns 2 or more and 10 or less non-dissociative hydrophilic substituents in a molecule and 1 or more dissociative hydrophilic substituents in a molecule. Therefore, though an expensive ligand such as an antibody is not needed, it is possible to capture and collect B-cells from a liquid containing B-cells with selectivity comparable to the antibody, and since stable to sterilization and can be processed in large quantities, it can be used as a B-cell separator used for extracorporeal circulation intended for removing cells selectively by filling it in a vessel having at least an inlet and an outlet.
申请公布号 JPH10286307(A) 申请公布日期 1998.10.27
申请号 JP19970108354 申请日期 1997.04.11
申请人 ASAHI MEDICAL CO LTD 发明人 KUNO SUSUMU;ONODERA HIROKAZU
分类号 A61M1/36;B01D39/14;B01J45/00;(IPC1-7):A61M1/36 主分类号 A61M1/36
代理机构 代理人
主权项
地址